Ontada Partners with Microsoft to Enhance Oncology Data Analytics
Ontada, a McKesson business focused on oncology real-world data and clinical insights, is teaming up with Microsoft to harness the power of Azure AI, specifically the Azure OpenAI Service. This collaboration aims to revolutionize the processing of over 150 million unstructured oncology document components. By efficiently handling such a vast amount of data, Ontada seeks to unlock critical clinical information that can lead to better patient care.
Transforming Unstructured Data into Actionable Insights
In the realm of healthcare, an overwhelming challenge faced by systems today is that nearly 80% of crucial data remains unstructured. This unstructured data includes clinical notes, lab test results, medical imaging, and financial records. Astonishingly, it’s estimated that around 97% of this valuable information often goes unexamined or ignored.
The Role of AI in Oncology
To combat the problem of unstructured data, the Ontada Data Science team has taken proactive measures by deploying Large Language Models (LLMs). These models are specifically designed to target approximately 100 essential oncology data elements spanning 39 different types of cancer. This initiative not only aims to streamline data processing but also aspires to enhance the quality and accuracy of patient information.
Expert Insights on Advanced Technologies
Tyler Bryson, Corporate Vice President of US Health & Public Sector Industries at Microsoft, shared his views on the collaboration, stating, "Our partnership with Ontada provides essential insights into what Microsoft Azure AI can achieve. We believe there’s immense potential to exponentially increase the processing power for this important data. Collaborating closely, we’ve seen remarkable improvements in Ontada's ability to access and utilize valuable clinical data.”
Innovative Solutions for Oncology Care
Ontada’s partnership with Microsoft represents a commitment to developing a robust and sustainable data platform for their clients. Their ON.Genuity platform merges innovative AI technology with an advanced common data model, producing comprehensive and clinically detailed real-world data sourced from their proprietary electronic health records, iKnowMed. This extensive data collection reflects the entire patient journey, ensuring that insights can significantly enhance cancer treatment outcomes.
About Ontada and its Commitment to Cancer Care
Ontada, as part of the McKesson Corporation, is dedicated to driving innovation in cancer care through data and technology. Their mission is rooted in providing precise insights right when they are needed the most, ultimately saving lives. They connect the full spectrum of the patient's journey with advanced analytics, influencing care strategies adopted by leading life sciences companies globally.
Investing in Cancer Research and Care
As patients battling cancer face unprecedented changes in treatment availability and quality, Ontada is committed to addressing the complexities in oncology. This initiative is crucial as the demand for new and effective cancer therapies continues to grow. Ontada plays a significant role in this landscape, helping to accelerate innovation and improve patient outcomes by collaborating with healthcare providers and researchers.
Frequently Asked Questions
What is the purpose of Ontada's collaboration with Microsoft?
Ontada's collaboration with Microsoft aims to utilize Azure AI technologies to process unstructured oncology data effectively, improving clinical insights and patient outcomes.
What challenges does unstructured data present in healthcare?
Unstructured data poses significant challenges, as up to 80% of essential medical information remains unprocessed, leading to missed opportunities for analysis and improved patient care.
How does the ON.Genuity platform support oncology?
The ON.Genuity platform integrates advanced AI with a common data model to gather and analyze real-world data across the entire patient journey, ultimately enhancing cancer care quality.
What are Large Language Models (LLMs) in this context?
LLMs are advanced AI tools used by the Ontada Data Science team to identify critical oncology data points across numerous cancer types, improving the efficiency of data processing.
How does Ontada contribute to improving cancer research?
Ontada facilitates cancer research by providing real-world data and insights, which help healthcare providers and researchers make informed decisions for better patient care.
